Psychopharmacology and Neurotherapeutics
This newly available award offers $20,000 ($10,00 per year) to one child and adolescent psychiatry 2nd year fellow or early career faculty annually to complete a two-year mentored research project in the area of psychopharmacology and/or neurotherapeutics, with a focus on practical and investigative work toward treatment for children and adolescents.
Parents’ Medication Guides
AACAP and the American Psychiatric Association (APA) have developed Parents’ Medication Guides to help individuals make informed decisions about treating mental disorders in children and adolescents.
The Toolbox was developed as a resource for AACAP members who may find it useful in assessing and monitoring care in some cases in their practice. It gives members immediate access to free downloadable instruments for use in clinical practice. The Toolbox is under review and will be updated in 2024.
AACAP News Articles
- Updates on Catatonia in Children and Adolescents (2023) by Boris Lorberg, MD, MBA, Raman Baweja, MD, MS, Eric Hazen, MD, and Robyn Thom, MD
- What is New in Substance Abuse Treatment? Nasal Naloxone is Available Without a Prescription (2023) by Sara Polley, MD, and Boris Lorberg, MD
- Issues of Different Generic vs. Brand Medications and Their Shortages (2023) by Boris Lorberg, MD, and Petronella Mbu, MD
- The Birth of an “Impairing Emotional Outbursts” R Code (2022) by Boris Lorberg, MD, Petronella Mbu, MD, and Gabrielle Carlson, MD
- ADHD Updates – What Can We Learn from the Expert? (2022) by Colin Whitworth, MD, Boris Lorberg, MD, and Jeffrey H. Newcorn, MD
- Toxicology Testing for Children, Adolescents, and Emerging Adults (CAEAs) Undergoing Treatment with Controlled Substances (2022) by Tatjana Josic, DO, Raman Baweja, MD, MS, Scott Krakower, DO, DFAACAP, and Patrice K. Malone, MD, PhD
- Ketamine Treatment of Pediatric Depression – What Can We Learn From the Experts? (2021) by Joshua Kriegel, MD, Boris Lorberg, MD, Michael Bloch, MD, and Jennifer Dwyer, MD, PhD
Committee-Sponsored Institutes at AACAP Annual Meetings
- 2023 Pediatric Psychopharmacology: Staying Ahead of the Curve
Co-Chairs: Robyn P. Thom, MD, and Robert L. Findling, MD, MBA
- 2022 An Update in Psychopharmacology Relevant to Clinical Practice
Co-Chairs: Timothy Wilens, MD, and Daphne Korczak, FRCPC, MD, MSC
- 2021 Advanced Psychopharmacology
Co-Chairs: Adelaide S. Robb, MD, and Charles A. Whitmore, MD
- 2020 An Update in Psychopharmacology Relevant to Clinical Practice: Focus on Psychopathology Overlap With Mood Dysregulation
Co-Chairs: Adelaide S. Robb, MD, and Timothy Wilens, MD
- 2019 Advanced Psychopharmacology
Co-Chairs: Adelaide Robb, MD, and Mai Uchida, MD
- 2018 An Advanced Update in Psychopharmacology Relevant to Clinical Practice
Co-Chairs: Timothy E. Wilens, MD, and Adelaide S. Robb, MD
Pediatric Psychopharmacology Update Institutes
- 2023 Impulsive Aggression Across Diagnoses
Co-Chairs: Jeffrey R. Strawn, MD, and Jean A. Frazier, MD
- 2022 Virtual Pediatric Psychopharmacology Update Institute: Working Hands-On With Master Clinicians
Co-Chairs: Gabrielle A. Carlson, MD, and James J. McGough, MD
- 2021 Virtual Pediatric Psychopharmacology Update Institute: Beyond One Size Fits All: Predicting Medication Response
Co-Chairs: Gabrielle A. Carlson, MD, and Jeffrey R. Strawn, MD
- 2020 Translating Advances in Pediatric Psychopharmacology into Practice: Molecules, Mechanisms, and Medications
Co-Chairs: James J. McGough, MD and Manpreet Kaur Singh, MD, MS
- 2019 Early Treatment Intervention: When, What, and For How Long?
Co-Chairs: Boris Birmaher, MD, and Gabrielle A. Carlson, MD
Psychopharmacology and Neurotherapeutics Committee
- Clinical Toolbox Update
- Treatment-Resistant Depression
For information on the Psychopharmacology and Neurotherapeutics Committee, please contact firstname.lastname@example.org.